Cargando…

Chronic Urticaria: The Need for Improved Definition

Detalles Bibliográficos
Autores principales:	Gómez, R. Maximiliano, Bernstein, Jonathan A., Ansotegui, Ignacio, Maurer, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Allergy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234868/ https://www.ncbi.nlm.nih.gov/pubmed/35769560 http://dx.doi.org/10.3389/falgy.2022.905677

Ejemplares similares

Disease Impact, Diagnostic Delay, and Unmet Medical Needs of Patients With Cholinergic Urticaria in German-Speaking Countries
por: Altrichter, Sabine, et al.
Publicado: (2022)

Urticaria in Pregnancy and Lactation
por: Kocatürk, Emek, et al.
Publicado: (2022)

Urticaria and mimickers of urticaria
por: Fok, Jie Shen, et al.
Publicado: (2023)

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia
por: García-Gómez, Elizabeth, et al.
Publicado: (2022)

The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations()
por: Sánchez-Borges, Mario, et al.
Publicado: (2021)

Comorbidities of Chronic Urticaria: A glimpse into a complex relationship
por: Papapostolou, Niki, et al.
Publicado: (2022)

Editorial: The complexity of urticaria
por: Makris, Michael, et al.
Publicado: (2023)

The many faces of pediatric urticaria
por: Sekerel, Bulent Enis, et al.
Publicado: (2023)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic
por: Haddad, Isabelle, et al.
Publicado: (2022)

Efficacy and safety of omalizumab therapy in urticaria vasculitis
por: Petrelli, Fiorella, et al.
Publicado: (2022)

Acute Urticaria and Anaphylaxis: Differences and Similarities in Clinical Management
por: Ensina, Luis Felipe, et al.
Publicado: (2022)

Influence of the Microbiome on Chronic Rhinosinusitis With and Without Polyps: An Evolving Discussion
por: Huntley, Kyle S., et al.
Publicado: (2021)

The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management()
por: Sánchez-Borges, Mario, et al.
Publicado: (2021)

166 Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNF & ALPHA; and MMP-9 Release
por: Falkencronec, Sidsel, et al.
Publicado: (2012)

Wheezing-Related Relevant Factors and the Role of Viral Bronchiolitis
por: Teijeiro, Alvaro, et al.
Publicado: (2021)

269 Refractory Chronic Urticaria Treated with Omalizumab
por: Saenz, Martinez, et al.
Publicado: (2012)

A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real‐world study in Belgium
por: Lapeere, H., et al.
Publicado: (2019)

Burden of chronic urticaria relative to psoriasis in five European countries
por: Balp, M.M., et al.
Publicado: (2017)

581 Chronic Urticaria and Infections
por: Aguilar, Nadia, et al.
Publicado: (2012)

White Paper on European Patient Needs and Suggestions on Chronic Type 2 Inflammation of Airways and Skin by EUFOREA
por: De Prins, Louise, et al.
Publicado: (2022)

Circulating microRNA signatures in patients with chronic Urticaria
por: Jerobin, Jayakumar, et al.
Publicado: (2023)

Management of chronic spontaneous urticaria: a worldwide perspective
por: Kolkhir, Pavel, et al.
Publicado: (2018)

Corrigendum on: White paper on European patient needs and suggestions on chronic type 2 inflammation of airways and skin by EUFOREA
por: De Prins, Louise, et al.
Publicado: (2022)

Impact of Omalizumab on Anaphylaxis in Patients Treated for Chronic Urticaria
por: Song, Xiaoting, et al.
Publicado: (2023)

Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
por: Claeys, N., et al.
Publicado: (2021)

Corrigendum: Patients Unmet Needs in Chronic Rhinosinusitis With Nasal Polyps Care: A Patient Advisory Board Statement of EUFOREA
por: Claeys, N., et al.
Publicado: (2021)

Chronic Spontaneous Urticaria: How to Measure It and the Need to Define Treatment Success
por: Armstrong, April W., et al.
Publicado: (2023)

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria
por: Giménez‐Arnau, Ana, et al.
Publicado: (2022)

The incidence of depression and anxiety disorders in spontaneous chronic urticaria patients
por: Bangera, Anushree, et al.
Publicado: (2023)

Definition of Recurrent Chronic Spontaneous Urticaria
por: MELÉ-NINOT, Gemma, et al.
Publicado: (2020)

593 Chronic Urticaria as First Sign of Sarcoidosis
por: Pérez-Bustamante, María Socorro, et al.
Publicado: (2012)

582 Chronic Urticaria Associated with Thyroid Disease
por: de Guadalupe Peñaloza-González, Flor, et al.
Publicado: (2012)

Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection
por: Virdi, Gurnam
Publicado: (2022)

Acquired Non-histaminergic Angioedema With C1q Autoantibody and Urticaria: A Case Report
por: Kochvar, Andrew P, et al.
Publicado: (2023)

554 Chronic Urticaria Quality of Life Questionnaire (Cu-Q2 Ol) and Urticaria Activity Score (Uas)
por: Aguilar, Nadia, et al.
Publicado: (2012)

“Chronic urticaria and obstructive sleep apnea: Is there a significant association?”()
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2021)

Guideline of Chronic Urticaria Beyond
por: Fine, Lauren M., et al.
Publicado: (2016)

585 Chronic Idiopathic Urticaria and Neglected Toxocara Infection
por: Qualizza, Rosanna, et al.
Publicado: (2012)

Severe exercise-induced anaphylaxis in a hot and humid area successfully treated with omalizumab: a case report
por: Mobayed, Hassan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59me47qpuratoblodf66h8q9gt